Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AstraZeneca Prices Iressa At 25% Discount To Gleevec; Launch In May

Executive Summary

AstraZeneca is launching the lung cancer agent Iressa at a 25% discount to Novartis' chronic myelogenous leukemia therapy Gleevec

You may also be interested in...



Erbitux Phase IV Trials To Study EGFR-Negative Populations

Bristol-Myers Squibb and ImClone's post-approval commitments include an examination of the efficacy of Erbitux in patients with EGFR-negative colorectal cancer

Erbitux Phase IV Trials To Study EGFR-Negative Populations

Bristol-Myers Squibb and ImClone's post-approval commitments include an examination of the efficacy of Erbitux in patients with EGFR-negative colorectal cancer

Iressa Clears FDA: Phase IV Symptom Trial Will Be First Shot At Full Approval

AstraZeneca's first chance to secure traditional approval for Iressa will be a randomized trial assessing symptom improvement in non-small cell lung cancer due to be submitted to the agency by June 2005

Related Content

UsernamePublicRestriction

Register

PS041759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel